Cite
MLA Citation
J. E. Gehin et al.. “FRI0645 Anti-drug antibodies to certolizumab pegol are associated with low drug levels and reduced clinical response at 3 months in patients with inflammatory joint diseases. data from the nor-dmard study..” Annals of the rheumatic diseases, vol. 77, n.d., p. 844. http://access.bl.uk/ark:/81055/vdc_100144729648.0x000050